- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01833442
Randomized Controlled Meditation Trial for Treating OCD
October 10, 2017 updated by: Euripedes C. Miguel, University of Sao Paulo
Randomized Controlled Meditation Trial for Treating OCD Comparing Kundalini Yoga Meditation Versus the Relaxation Response
The trial objective is to compare two very different meditation protocols (Kundalini Yoga and Relaxation Response meditation techniques) to help the OCD treatment.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The proposed trial comparing the two different meditation protocols is expected to have two phases: 0-month to 4.5-month period where we compare the Kundalini Yoga protocol with Relaxation Response meditation technique, both on the primary efficacy variable using the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and some if not most of the secondary variables using The Dimensional Yale-Brown Obsessive Compulsive Scale (DY-BOCS), Clinical Global Impressions (CGI), Profile of Mood States (POMS), Beck Anxiety Inventory (Beck-A), Beck Depression Inventory (Beck-D), and SF-36 Health Status Questionnaire (SF36).
Participants will go to the hospital once a week for a 1,5 hour meditation class.After 4.5-months, all patients will be evaluated and merged together into a single group.
Patients will then receive 09 to 12 more months of the meditation protocol.
The investigators are expecting to recruit 50 to 60 patients to start.
Patients will be blinded to the content of the protocol in the other group at baseline and until one group shows greater efficacy on the primary efficacy variable.
The intake physician will be blinded to the treatment groups of the patients.
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
São Paulo
-
Sao Paulo, São Paulo, Brazil, 01454-010
- University of Sao Paulo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Clinical diagnosis of OCD for at least 6 months.
- A minimum score of 16 on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) for the 10-item total score at the baseline screening will be required.
- The patient must sign and been provided with a copy of an Assent Form for their reference.
Exclusion Criteria:
- Psychoactive prescription medications other than those prescribed for OCD.
- Spinal problems, or other physically limiting problems.
- Clinical diagnosis of hypertension, or other cardiovascular problems.
- Clinical diagnosis of Parkinson's disease.
- Clinical diagnosis of major depressive disorder with psychotic features, schizophrenia, bipolar disorder, mental retardation, anorexia nervosa, bulimia nervosa, autistic disorder, Asperger's disorder and other forms of pervasive developmental disorder, or traumatic brain.
- Clinical diagnosis of Tourette's Syndrome.
- Patients without regular and reliable transportation to the study site.
- Patients who choose not to participate in meditation and/or chanting (out loud or silently) for personal or religious reasons.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Kundalini Yoga Meditation
Kundalini Yoga Meditation is going to be use as therapy for OCD, and it will be compare with Relaxation Response Meditation.
|
The trial will compare two very different meditation protocols.
After the 4.5 month the patients will be reevaluated, and all patients will be merged together into a single group.
Patients will then receive 9 - 12 more months of the meditation protocol.
|
|
Active Comparator: Relaxation Response Meditation
Relaxation Response Meditation is going to be use as therapy for OCD, and it will be compare with Kundalini Yoga Meditation.
|
The trial will compare two very different meditation protocols.
After the 4.5 month the patients will be reevaluated, and all patients will be merged together into a single group.
Patients will then receive 9 - 12 more months of the meditation protocol.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Yale-Brown Obsessive Compulsive Scale (YBOCS)
Time Frame: Up to 16 months
|
The Yale-Brown Obsessive Compulsive Scale, sometimes referred to as Y-BOCS, is a test to rate the severity of obsessive-compulsive disorder (OCD) symptoms.
|
Up to 16 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS)
Time Frame: Up to 16 months
|
The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions.
|
Up to 16 months
|
|
Clinical Global Impressions (CGI)
Time Frame: Up to 16 months
|
Up to 16 months
|
|
|
Profile of Mood States (POMS)
Time Frame: Up to 16 months
|
Up to 16 months
|
|
|
Beck Anxiety Inventory (Beck-A)
Time Frame: Up to 16 months
|
Up to 16 months
|
|
|
Beck Depression Inventory (Beck-D)
Time Frame: Up to 16 months
|
Up to 16 months
|
|
|
SF-36 Health Status Questionnaire (SF36)
Time Frame: Up to 16 months
|
Up to 16 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Euripedes C Miguel, PHD, University of Sao Paulo
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2011
Primary Completion (Actual)
July 1, 2013
Study Completion (Actual)
July 1, 2013
Study Registration Dates
First Submitted
December 4, 2012
First Submitted That Met QC Criteria
April 12, 2013
First Posted (Estimate)
April 16, 2013
Study Record Updates
Last Update Posted (Actual)
October 11, 2017
Last Update Submitted That Met QC Criteria
October 10, 2017
Last Verified
October 1, 2017
More Information
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on OCD
-
Boston University Charles River CampusRecruiting
-
University of PennsylvaniaNational Institute of Mental Health (NIMH); New York University; New York State... and other collaboratorsRecruiting
-
University of MinnesotaU.S. National Science FoundationCompleted
-
Han Joo LeePsi ChiRecruiting
-
University of FloridaInternational OCD FoundationRecruiting
-
University of MinnesotaNational Institute of Mental Health (NIMH)Completed
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...Unknown
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...Recruiting
Clinical Trials on Kundalini Yoga Meditation
-
Research Foundation for Mental Hygiene, Inc.WithdrawnPost-Treatment Lyme Disease
-
University of California, Los AngelesAlzheimer's Research and Prevention Foundation (ARPF)CompletedMild Cognitive Impairment | Alzheimer's DiseaseUnited States
-
Research Foundation for Mental Hygiene, Inc.TerminatedPost Treatment Lyme Disease SyndromeUnited States
-
University of California, Los AngelesCompletedMajor Depressive Disorder | Depression NOS | Anxiety NOSUnited States
-
Research Foundation for Mental Hygiene, Inc.Active, not recruitingGeneralized Anxiety | Health AnxietyUnited States
-
Lady Davis InstituteKripalu Institute and the Mind and Life InstituteCompleted
-
Karolinska InstitutetSwedish Council for Working Life and Social ResearchCompleted
-
NYU Langone HealthNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Georgetown UniversityCompletedStress Disorders, Post-TraumaticUnited States
-
Dartmouth-Hitchcock Medical CenterCompleted